Effects of progesterone and R2323 on the development of dimethylbenzanthracene-induced mammary tumors

Eur J Cancer (1965). 1979 Oct;15(10):1243-51. doi: 10.1016/0014-2964(79)90250-0.
No abstract available

MeSH terms

  • 9,10-Dimethyl-1,2-benzanthracene
  • Animals
  • Body Weight / drug effects
  • Dose-Response Relationship, Drug
  • Estradiol / metabolism
  • Female
  • Gestrinone / therapeutic use*
  • Mammary Neoplasms, Experimental / chemically induced*
  • Mammary Neoplasms, Experimental / drug therapy
  • Mammary Neoplasms, Experimental / metabolism
  • Norpregnatrienes / therapeutic use*
  • Progesterone / toxicity*
  • Prolactin / metabolism
  • Promegestone / metabolism
  • Rats
  • Receptors, Cell Surface / metabolism
  • Receptors, Estrogen / metabolism
  • Receptors, Progesterone / metabolism

Substances

  • Norpregnatrienes
  • Receptors, Cell Surface
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Gestrinone
  • Progesterone
  • Estradiol
  • 9,10-Dimethyl-1,2-benzanthracene
  • Prolactin
  • Promegestone